Johns Hopkins Medicine–led team shows technique can find protein fragments that best stimulate the immune system to recognize and attack the virus.

Increased investments, innovation, and focus on equity are vitally needed to end the HIV epidemic.

Study from Boston Medical Center.

Large NIH study findings.

New study.

NIH-funded study confirms white blood cell subtype as HIV reservoir, suggests new target for cure efforts.

Strengthened global health security.

NIH-supported study demonstrates injectable ART may improve outcomes in underserved patients.

Since 2015, only about 1.2 million people have been considered ‘at risk’ of HIV and potentially able to benefit from pre-exposure prophylaxis, also known as PrEP, according to...

The clinical trial began in 2019 and involved 3,900 volunteers.